A 79-year old male patient was admitted with hemoptysis and anemia. Eight years previously he underwent wrapping of a thoracic aortic aneurysm. Magnetic resonance angiography (MRA) disclosed a thoracic aortic aneurysm, which was ruptured into the left bronchus. This was successfully treated with two Endofit thoracic stent grafts.
Introduction
Aortobronchial fistula (ABF) is a rare but life threatening complication, 1 which typically occurs following thoracic aortic surgery. 2, 3 The classic treatment is conventional open-repair, which is associated with high morbidity and mortality.
Recent advances in endovascular surgery have made it possible to treat aortoesophageal and aortobronchial fistulae with a stent, a less invasive alternative to open surgical treatment. While there are no long-term studies available, these procedures appear to offer lower rates of mortality and morbidities in the treatment of such pathologies.
The first endovascular exclusions of aortic aneurysms using an endoluminal graft were reported by Volodos in Kiev (1986) and Parodi in Buenos Aires in 1990. [4] [5] [6] Since then, a great variety of aortic pathologies have been treated using endovascular techniques. These include aneurysms, penetrating ulcers, dissections and aortobronchial as well as aortoesophageal fistulae. Increasingly, such techniques become a treatment option for lesions in various vascular territories.
We present the successful repair of an ABF using endoluminal self-expandable stent grafts.
Case Report
A 79-year old male patient was admitted with hemoptysis and anemia (HctZ32%). Eight years ago, he underwent a left thoracotomy and wrapping of a thoracic aortic aneurysm, distal to the left subclavian artery. Magnetic resonance angiography (MRA) disclosed a thoracic aortic aneurysm, which was ruptured into the left bronchus ( Figs. 1 and 2 ). During hospitalization, he developed massive hemoptysis, resulting into hemorrhagic shock and dyspnea, requiring endotracheal intubation. Prompt surgical intervention was necessary, in order to avoid other potentially fatal complications.
Primarily, we gained intravascular access through the common femoral arteries. Using fluoroscopic techniques, a preloaded Endofit thoracic stent graft (Endomed, Phoenix AZ, USA) 40 mm in diameter and 16 cm in length, loaded in a 22F sheath, was placed into the thoracic aorta, over a stiff 0.035 Amplatz guidewire. An angiographic 5F pigtail catheter was inserted to the brachial artery extending to the thoracic arch to mark the origin of the left subclavian artery. A 7F Arrow sheath was percutaneously inserted through the left femoral artery and guided up to the diaphragmatic aorta, close to the celiac artery, to control the lowest level of the grafts' deployment. Two grafts (40 mm!16 cm, 38 mm!18 cm) were required, to cover the full length of the aneurysm. All devices were deployed under fluoroscopic control. Completion arteriogram was performed to ensure accurate placement and rule out endo-leaks. The patient was kept into intensive care unit for 12 h and post-operative scans indicated complete exclusion of the aneurysm (Figs. 3 and 4) . The patient was discharged after 7 days in good condition. Five months later he was reevaluated in our department and was in good condition. Seven months after the procedure the patient was diagnosed with an abdominal aortic aneurysm, but he refused any intervention as the condition could not be treated using an endovascular technique, due to anatomic abnormalities.
Discussion
Aortobronchial fistula (ABF) is a potentially deadly aortic surgery complication, even though it is quite rare. In most cases, it is reported following aortic dissection, valvular heart disease repair, coarctation and most commonly after the surgical repair of aortic aneurysms. [7] [8] [9] [10] [11] ABF is typically difficult to diagnose. In some cases repeated diagnostic tests, including various imaging techniques, can prove inadequate for the diagnosis of an ABF. 12, 13 A common symptom, though, is hemoptysis, which may be fatal. 1, 14, 15 Once the presence of an ABF has been diagnosed, prompt intervention is vital. 16 Open surgery is the conventional treatment and typically involves thoracotomy, aortic cross-clamping, possible cardiopulmonary bypass and pulmonary tissue dissection. All these, in addition to the fact that fistulae presenting patients are already at high risk for open surgery managements, due to hemodynamic instability and comorbidities, make open surgery risky. Modern endovascular techniques offer a less invasive approach for the repair of such lesions, with potentially better results, based on the early clinical data. 16 We used two endofit stent grafts in the thoracic aorta. The endofit device is composed of nitinol stents combined with expandable polytetrafluoroethylene (ePTFE) fabric, with an uncovered proximal stent, and comes loaded in a cartridge. Each stent is separated from the others, and only the top 'freeflow' stent is linked to the first covered stent. All stents, except the proximal free-flow stent, are sandwiched between two layers of ePTFE in a thermal process of encapsulation that avoids the need for sutures. 17 Data available from the patient's follow-up, reveal that the endoluminal stent-grafting of ABF is not only feasible, but appears to have a lower rate of morbidities and mortality, compared to open surgery. In addition to this, the procedure is less complicated and less invasive, offering better life-quality for the patients involved.
The endovascular repair of an ABF using endoluminal stent grafts offers several of advantages, compared to open surgery repair. Further studies are needed to determine the safety and efficacy of the method. The early clinical experience suggests that it is satisfactory. 18 
